Horizon Pharma Catapults On VIMOVO Prospects (NASDAQ:HZNP)

Horizon Pharma, Inc. (NASDAQ:HZNP)

With analyst expectations, the global pharmaceutical market could touch $1.6 trillion by 2020. Take a look at Horizon Pharma ticker symbol HZNP. Horizon Pharma is a specialty pharmaceutical company that has developed and is commercializing products to primary care, orthopedic surgeons and rheumatologists. This Company has currently surged +34.79% Up 1.56 with over 12.5 million shares in play Tuesday November 19, 2013 3:53PM EST. So why is this stock attracting major investors on wall street, up around a buck and half you ask? All we know is this.

Horizon Pharma entered into an agreement to acquire the U.S. rights to arthritis treatment VIMOVO® and reported pricing of $150 million of 5.00% convertible senior notes. What make this stock hot is that the Company (www.horizonpharma.com) has began to realize that they must increase their commercial fundamentals to reach profitability by next year. One of our cardinal rules are capital represents the stockholders equity. Since AstraZeneca scored $5 million in Q3 2013 sales of VIMOVO® in the United States, I would not be surprised to witness Horizon Pharma catapult in 2014.

****

Crown Equity Holdings Inc. (OTCMKTS:CRWE)

Since U.S. ecommerce figures are predicted to generate around $262.3 billion in 2013 sales from internet transactions, look at Crown Equity Holdings Inc. ticker symbol CRWE. Crown Equity Holdings provides a large array of network services including website distribution and development, investor relations, human resources, video streaming through CRWETube (http://crwetube.com/) and advertisement. The ace with the kicker concerning Crown Equity Holdings (http://crownequityholdings.com) is iB2B Global.

iB2B Global is a global B2B trade online directory for wholesale and retailers. To view iB2B Global short form business plan visit URL(http://crownequityholdings.com/extras/iB2BGlobal_business_plan.pdf) via the web. iB2B Global hopes to reach $10 to $15 million in total EBITA by the end of their third year. Crown Equity Holdings has gained +718.18% positive traction concerning their 52 week low. Smart analyst could predict that Crown Equity Holdings is in a great position concerning investor returns, as the United States technical sector is expected to grow around 7.5% by the end of this year.

Remember: Always do your homework and consult your own financial professional.

Read Full Disclaimer at http://stockhottips.com/disclaimer/